FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tomasz Burzykowski

Research Profile

Concepts & Ideas

Procedures

Disorders

Living Beings

Cattle

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Piotr Dittwald; Tomasz Burzykowski; Jürgen Claesen; Dirk Valkenborg; Anna Gambin
BRAIN: a universal tool for high-throughput calculations of the isotopic distribution for mass spectrometry.
Jürgen Claesen; Lieven Clement; Maria R Foulquié-Moreno; Ziv Shkedy; Tomasz Burzykowski
Simultaneous mapping of multiple gene loci with pooled segregants.
David Venet; Veronique Wilson; Ursula Becker; François Beckers; Valerie Bee; Tomasz Burzykowski; Erik Doffagne; Eric Genevois-Marlin; Catherine Legrand; Yves Tellier; Marc Buyse
A statistical approach to central monitoring of data quality in clinical trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tomasz Burzykowski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Piotr Dittwald; Tomasz Burzykowski; Jürgen Claesen; Dirk Valkenborg; Anna Gambin
BRAIN: a universal tool for high-throughput calculations of the isotopic distribution for mass spectrometry.
Analytical chemistry 2013;85(4):1991-4.
2013: Jürgen Claesen; Lieven Clement; Maria R Foulquié-Moreno; Ziv Shkedy; Tomasz Burzykowski
Simultaneous mapping of multiple gene loci with pooled segregants.
PloS one 2013;8(2):e55133.
2012: David Venet; Veronique Wilson; Ursula Becker; François Beckers; Valerie Bee; Tomasz Burzykowski; Erik Doffagne; Eric Genevois-Marlin; Catherine Legrand; Yves Tellier; Marc Buyse
A statistical approach to central monitoring of data quality in clinical trials.
Clinical trials (London, England) 2012;9(6):705-13.
2012: Andrzej mackiewicz; Jacek Mackiewicz; Stefan Rose-John; Maciej Wiznerowicz; Piotr J Wysocki; Tomasz Burzykowski; D Izycki; M Kapcinska; M Laciak; Aldona Karczewska-Dzionk
Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection.
Expert opinion on investigational drugs 2012;21(6):773-83.
2012: Jürgen Claesen; Piotr Dittwald; Tomasz Burzykowski; Dirk Valkenborg
An efficient method to calculate the aggregated isotopic distribution and exact center-masses.
Journal of the American Society for Mass Spectrometry 2012;23(4):753-63.
2012: Stuart G Baker; Marc Buyse; Daniel J Sargent; Tomasz Burzykowski
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time.
Biometrics 2012;68(1):248-57.
2011: Marc Buyse; Sylvie Castaigne; Sylvie Chevret; Stephen L George; Jonathan E Kolitz; Beverly J Lange; Richard A Larson; Kathryn J Lucchesi; Dominique Maraninchi; Pierre Squifflet; Todd A Alonzo; Didier Blaise; Clara D Bloomfield; Tomasz Burzykowski
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.
Blood 2011;117(26):7007-13.
2011: Qi Zhu; Tomasz Burzykowski
A Bayesian Markov-chain-based heteroscedastic regression model for the analysis of 18O-labeled mass spectra.
Journal of the American Society for Mass Spectrometry 2011;22(3):499-507.
2011: Tomasz Burzykowski; M Buyse
The correlation structure of longitudinal measurements of vision in patients with macular degeneration.
Pharmaceutical statistics 2011;10(2):115-21.
2011: Qi Zhu; Adetayo Kasim; Dirk Valkenborg; Tomasz Burzykowski
A bayesian model averaging approach to the quantification of overlapping peptides in an maldi-tof mass spectrum.
International journal of proteomics 2011;2011():928391.
2011: Dirk Valkenborg; Tomasz Burzykowski
A Markov-chain model for the analysis of high-resolution enzymatically 18O-labeled mass spectra.
Statistical applications in genetics and molecular biology 2011;10():Article 1.
2010: Tomasz Burzykowski; James Carpenter; Corneel Coens; Daniel Evans; Lesley France; Mike Kenward; Peter Lane; James Matcham; David Morgan; Alan Phillips; James Roger; Brian Sullivan; Ian White; Ly-Mee Yu
Missing data: discussion points from the PSI missing data expert group.
Pharmaceutical statistics 2010;9(4):288-97.
2010: Geert Molenberghs; Tomasz Burzykowski; Ariel Alonso; Pryseley Assam; Abel Tilahun; Marc Buyse
A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.
Statistical methods in medical research 2010;19(3):205-36.
2010: Qi Zhu; Dirk Valkenborg; Tomasz Burzykowski
Markov-chain-based heteroscedastic regression model for the analysis of high-resolution enzymatically 18O-labeled mass spectra.
Journal of proteome research 2010;9(5):2669-77.
2010: Xavier Paoletti; Koji Oba; Tomasz Burzykowski; Stefan Michiels; Yasuo Ohashi; Jean-Pierre Pignon; Philippe Rougier; Junichi Sakamoto; Daniel Sargent; Mitsuru Sasako; Eric Van Cutsem; Marc Buyse
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
JAMA : the journal of the American Medical Association 2010;303(17):1729-37.
2009: Stefan Michiels; Aurélie Le Maître; Marc Buyse; Tomasz Burzykowski; Emilie Maillard; Jan Bogaerts; Jan B Vermorken; Wilfried Budach; Thomas F Pajak; Kian K Ang; Jean Bourhis; Jean-Pierre Pignon
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
The lancet oncology 2009;10(4):341-50.
2009: Dirk Valkenborg; Grégoire Thomas; Luc Krols; Koen Kas; Tomasz Burzykowski
A strategy for the prior processing of high-resolution mass spectral data obtained from high-dimensional combined fractional diagonal chromatography.
Journal of mass spectrometry : JMS 2009;44(4):516-29.
2008: D Lin; Z Shkedy; Tomasz Burzykowski; R Ion; Hinrich Göhlmann; A De Bondt; T Perer; T Geerts; I Van den Wyngaert; Luc Bijnens
An investigation on performance of Significance Analysis of Microarray (SAM) for the comparisons of several treatments with one control in the presence of small-variance genes.
Biometrical journal. Biometrische Zeitschrift 2008;50(5):801-23.
2008: Tomasz Burzykowski
Surrogate endpoints: wishful thinking or reality?
Statistical methods in medical research 2008;17(5):463-6.
2008: Marc Buyse; Tomasz Burzykowski; Stefan Michiels; Kevin Carroll
Individual- and trial-level surrogacy in colorectal cancer.
Statistical methods in medical research 2008;17(5):467-75.
2008: Goele Massonnet; Paul Janssen; Tomasz Burzykowski
Fitting conditional survival models to meta-analytic data by using a transformation toward mixed-effects models.
Biometrics 2008;64(3):834-42.
2008: Dirk Valkenborg; Ivy Jansen; Tomasz Burzykowski
A model-based method for the prediction of the isotopic distribution of peptides.
Journal of the American Society for Mass Spectrometry 2008;19(5):703-12.
2008: Tomasz Burzykowski; Marc Buyse; Martine J Piccart-Gebhart; George Sledge; James Carmichael; Hans-Joachim Lück; John R Mackey; Jean-Marc Nabholtz; Robert Paridaens; Laura Biganzoli; Jacek Jassem; Marijke Bontenbal; Jacques Bonneterre; Stephen Chan; Gul Atalay Basaran; Patrick Therasse
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1987-92.
2008: Martine J Piccart-Gebhart; Tomasz Burzykowski; Marc Buyse; George Sledge; James Carmichael; Hans-Joachim Lück; John R Mackey; Jean-Marc Nabholtz; Robert Paridaens; Laura Biganzoli; Jacek Jassem; Marijke Bontenbal; Jacques Bonneterre; Stephen Chan; Gul Atalay Basaran; Patrick Therasse
Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1980-6.
2008: Niko Speybroeck; Tanguy Marcotty; Marc Aerts; Tom Dolan; Brian Williams; Jeremy Lauer; Geert Molenberghs; Tomasz Burzykowski; Misheck Mulumba; Dirk Berkvens
Titrating Theileria parva: single stocks against combination of stocks.
Experimental parasitology 2008;118(4):522-30.
2008: Tomasz Burzykowski; Marc Buyse; Greg Yothers; Junichi Sakamoto; Dan Sargent
Exploring and validating surrogate endpoints in colorectal cancer.
Lifetime data analysis 2008;14(1):54-64.
2008: Dirk Valkenborg; Suzy Van Sanden; Dan Lin; Adetayo Kasim; Qi Zhu; Philippe Haldermans; Ivy Jansen; Ziv Shkedy; Tomasz Burzykowski
A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry.
Statistical applications in genetics and molecular biology 2008;7(2):Article12.
2007: Laurence Collette; Marc Buyse; Tomasz Burzykowski
Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5673-4; author reply 5674.
2007: Marc Buyse; Tomasz Burzykowski; Kevin Carroll; Stefan Michiels; Daniel J Sargent; Langdon L Miller; Gary L Elfring; Jean-Pierre Pignon; Pascal Piedbois
Progression-free survival is a surrogate for survival in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5218-24.
2007: Aimery de Gramont; Marc Buyse; Jose Cortinas Abrahantes; Tomasz Burzykowski; Emmanuel Quinaux; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Christophe Tournigand
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3224-9.
2007: Dan Lin; Ziv Shkedy; Dani Yekutieli; Tomasz Burzykowski; Hinrich Göhlmann; An De Bondt; Tim Perera; Tamara Geerts; Luc Bijnens
Testing for trends in dose-response microarray experiments: a comparison of several testing procedures, multiplicity and resampling-based inference.
Statistical applications in genetics and molecular biology 2007;6():Article26.
2007: Dirk Valkenborg; Pryseley Assam; Grégoire Thomas; Luc Krols; Koen Kas; Tomasz Burzykowski
Using a Poisson approximation to predict the isotopic distribution of sulphur-containing peptides in a peptide-centric proteomic approach.
Rapid communications in mass spectrometry : RCM 2007;21(20):3387-91.
2007: Philippe Haldermans; Ziv Shkedy; Suzy Van Sanden; Tomasz Burzykowski; Marc Aerts
Using linear mixed models for normalization of cDNA microarrays.
Statistical applications in genetics and molecular biology 2007;6():Article 19.
2006: Tomasz Burzykowski; Marc Buyse
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation.
Pharmaceutical statistics 2006;5(3):173-86.
2006: Laurence Collette; Tomasz Burzykowski; Fritz H Schröder
Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1344-50.
2006: Joris Vanderlocht; Tomasz Burzykowski; Veerle Somers; Piet Stinissen; Niels Hellings
No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosis.
Journal of neuroimmunology 2006;171(1-2):189-92.
2006: Suzy Van Sanden; Luc Wouters; Tomasz Burzykowski; Geert Molenberghs; Marie Van Remoortere; Theo F Meert; Luc Bijnens
A modeling approach to the analysis of nerve regenerative experiments.
Journal of biopharmaceutical statistics 2006;16(6):843-59.
2006: Suzy Van Sanden; Tomasz Burzykowski
The use of background signal in the transformation of cDNA-microarray measurements.
Applied bioinformatics 2006;5(3):161-72.
2005: José Cortiñas Abrahantes; Tomasz Burzykowski
A version of the EM algorithm for proportional hazard model with random effects.
Biometrical journal. Biometrische Zeitschrift 2005;47(6):847-62.
2005: Simone G J van Breda; Ebienus van Agen; Suzy Van Sanden; Tomasz Burzykowski; Jos C S Kleinjans; Joost H van Delft
Vegetables affect the expression of genes involved in carcinogenic and anticarcinogenic processes in the lungs of female C57BL/6 mice.
The Journal of nutrition 2005;135(11):2546-52.
2005: Laurence Collette; Tomasz Burzykowski; Kevin J Carroll; Don Newling; Tom Morris; Fritz H Schröder
Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6139-48.
2005: Simone G J van Breda; Ebienus van Agen; Suzy Van Sanden; Tomasz Burzykowski; Anne S Kienhuis; Jos C S Kleinjans; Joost H M van Delft
Vegetables affect the expression of genes involved in anticarcinogenic processes in the colonic mucosa of C57BL/6 female mice.
The Journal of nutrition 2005;135(8):1879-88.
2005: F Boelaert; Niko Speybroeck; A de Kruif; Marc Aerts; Tomasz Burzykowski; Geert Molenberghs; Dirk Berkvens
Risk factors for bovine herpesvirus-1 seropositivity.
Preventive veterinary medicine 2005;69(3-4):285-95.
2005: Roel Straetemans; Timothy O'Brien; Luc Wouters; Jacky Van Dun; Michel Janicot; Luc Bijnens; Tomasz Burzykowski; Marc Aerts
Design and analysis of drug combination experiments.
Biometrical journal. Biometrische Zeitschrift 2005;47(3):299-308.
2005: Rosemary Nguti; Tomasz Burzykowski; John Rowlands; Didier Renard; Paul Janssen
Joint modelling of repeated measurements and event time: application to performance traits and survival of lambs bred in sub-humid tropics.
Genetics, selection, evolution : GSE 2005;37(2):175-97.
2005: vincent vinh-hung; Tomasz Burzykowski; Jan Van de Steene; Mia Voordeckers; Jan Lamote; Guy Storme
Statistical interaction in the survival analysis of early breast cancer using registry data: role of breast conserving surgery and radiotherapy.
Tumori 2005;91(1):9-14.
2004: Gábor Cserni; Tomasz Burzykowski; vincent vinh-hung; Lajos Kocsis; Gábor Boross; Mária Sinkó; Miklós Tarján; Rita Bori; Mária Rajtár; Eliza Tekle; Róbert Maráz; Béla Baltás; Mihály Svébis
Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer.
Japanese journal of clinical oncology 2004;34(9):519-24.
2004: Ariel Alonso; Geert Molenberghs; Tomasz Burzykowski; Didier Renard; Helena Geys; Ziv Shkedy; Fabián Tibaldi; José Cortiñas Abrahantes; Marc Buyse
Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints.
Biometrics 2004;60(3):724-8.
2004: Geert Molenberghs; Tomasz Burzykowski; Ariel Alonso; Marc Buyse
A perspective on surrogate endpoints in controlled clinical trials.
Statistical methods in medical research 2004;13(3):177-206.
2004: Fabián Tibaldi; Geert Molenberghs; Tomasz Burzykowski; Helena Geys
Pseudo-likelihood estimation for a marginal multivariate survival model.
Statistics in medicine 2004;23(6):947-63.
2004: Junichi Sakamoto; Yasuo Ohashi; Chikuma Hamada; Marc Buyse; Tomasz Burzykowski; Pascal Piedbois
Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):484-92.
2004: Tomasz Burzykowski; Wiktor Chmielarczyk
Predicted and observed thyroid cancer incidence in Poland after year 1986.
Wiadomości lekarskie (Warsaw, Poland : 1960) 2004;57(7-8):306-10.
2003: Niko Speybroeck; F Boelaert; Didier Renard; Tomasz Burzykowski; Koen Mintiens; Geert Molenberghs; Dirk Berkvens
Design-based analysis of surveys: a bovine herpesvirus 1 case study.
Epidemiology and infection 2003;131(2):991-1002.
2003: Marc Buyse; Tomasz Burzykowski; Mahesh Parmar; Valter Torri; George Omura; Nicoletta Colombo; Chris Williams; Pierfranco Conte; Jan Vermorken
Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1682-7.
2003: vincent vinh-hung; Tomasz Burzykowski; Gábor Cserni; Mia Voordeckers; Jan Van de Steene; Guy Storme
Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer.
International journal of oncology 2003;22(3):697-704.
2003: vincent vinh-hung; Gábor Cserni; Tomasz Burzykowski; Jan Van de Steene; Mia Voordeckers; Guy Storme
Effect of the number of uninvolved nodes on survival in early breast cancer.
Oncology reports 2003;10(2):363-8.
2003: Jaroslaw Regula; Ewa E Hennig; Tomasz Burzykowski; Janina Orlowska; Krzysztof Przytulski; Marcin Polkowski; Anna Dziurkowska-Marek; Tomasz Marek; Andrzej Nowak; Eugeniusz Butruk; Jerzy Ostrowski
Multivariate analysis of risk factors for development of duodenal ulcer in Helicobacter pylori-infected patients.
Digestion 2003;67(1-2):25-31.
2002: Geert Molenberghs; Marc Buyse; Helena Geys; Didier Renard; Tomasz Burzykowski; Ariel Alonso
Statistical challenges in the evaluation of surrogate endpoints in randomized trials.
Controlled clinical trials 2002;23(6):607-25.
2002: Gábor Cserni; vincent vinh-hung; Tomasz Burzykowski
Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?
Journal of surgical oncology 2002;81(2):63-9.
2002: vincent vinh-hung; Tomasz Burzykowski; Jan Van de Steene; Guy Storme; Guy Soete
Post-surgery radiation in early breast cancer: survival analysis of registry data.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;64(3):281-90.
2001: Marc Buyse; P Thirion; R W Carlson; Tomasz Burzykowski; G Molenberghs; Pascal Piedbois
Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.
Journal of the National Cancer Institute 2001;93(5):399-401.
2000: Marc Buyse; P Thirion; R W Carlson; Tomasz Burzykowski; G Molenberghs; Pascal Piedbois
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer.
Lancet 2000;356(9227):373-8.